| Name | Title | Contact Details |
|---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
Veterans Evaluation Services is a company that supports the U.S. Department of Veterans Affairs in providing veterans and transitioning service members with the benefits theyve earned through their service to the country. They provide high quality, ti...
Greenlight is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CompassCare is a Bannockburn, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Wellnet Healthcare is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.